No other clear clinical manifestation besides diabetes has been described for patients with heterozygous mutations in KLF11 (MODY7), ABCC8 (MODY12), KCNJ11 (MODY13), and APPL1 (MODY14). This evidence concerns the gene KCNJ11 and diabetes mellitus.